WYETH AND PFIZER AGREE TO PAY $784.6 MILLION TO RESOLVE ALLEGATIONS OF UNDERPAYING REBATES OWED UNDER THE MEDICAID DRUG REBATE PROGRAM
AUGUSTA ? Attorney General Janet T. Mills announced today that Maine has reached an agreement in principle to settle allegations against the drug-maker Wyeth, a wholly owned subsidiary of Pfizer, Inc. The settlement will resolve allegations that Wyeth knowingly underpaid rebates owed under the Medicaid Drug Rebate Program for the sales of Protonix Oral and Protonix IV between 2001 and 2006. Under the settlement Wyeth has agreed to pay $784.6 million to the United States and the States. Over $371 million of this amount will go to the Medicaid Program.